Medexus Pharmaceuticals Inc.
MEDXF
$3.50
-$0.05-1.46%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.68M | 80.00K | -315.00K | 516.00K | -553.00K |
| Total Depreciation and Amortization | 2.46M | 2.42M | 2.43M | 2.43M | 2.44M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.20M | 1.48M | 1.51M | 397.00K | -226.00K |
| Change in Net Operating Assets | 804.00K | 3.85M | -290.00K | 580.00K | 619.00K |
| Cash from Operations | 3.79M | 7.83M | 3.34M | 3.92M | 2.28M |
| Capital Expenditure | -3.00K | -19.00K | -7.00K | -125.00K | -53.00K |
| Sale of Property, Plant, and Equipment | 0.00 | -- | -- | 653.00K | -- |
| Cash Acquisitions | -478.00K | -407.00K | -1.65M | -369.00K | -2.01M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.50M | -5.00M | -- | -2.50M | 0.00 |
| Cash from Investing | -7.98M | -5.43M | -1.66M | -2.34M | -2.06M |
| Total Debt Issued | -2.00K | 25.58M | -- | -- | -- |
| Total Debt Repaid | -3.13M | -21.54M | -1.16M | -15.55M | -3.36M |
| Issuance of Common Stock | 495.00K | -- | -- | -- | 19.30M |
| Repurchase of Common Stock | -1.16M | -375.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -380.00K | -516.00K | -442.00K | -739.00K | -779.00K |
| Cash from Financing | -4.17M | 3.14M | -1.60M | -16.29M | 15.17M |
| Foreign Exchange rate Adjustments | -85.00K | 47.00K | -34.00K | 72.00K | 153.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.45M | 5.59M | 49.00K | -14.64M | 15.53M |